What is Oncolytics Biotech, Inc. Common Shares's Market Cap?

Oncolytics Biotech, Inc. Common Shares's Market Cap is $64.0M, based on as-reported figures from SEC (XBRL) filings.

What is Oncolytics Biotech, Inc. Common Shares's Enterprise Value?

Oncolytics Biotech, Inc. Common Shares's Enterprise Value is $59.9M, based on as-reported figures from SEC (XBRL) filings.

What is Oncolytics Biotech, Inc. Common Shares's EV / EBITDA?

Oncolytics Biotech, Inc. Common Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Oncolytics Biotech, Inc. Common Shares's Net Income (TTM)?

Oncolytics Biotech, Inc. Common Shares's Net Income (TTM) is -$37.5M, based on as-reported figures from SEC (XBRL) filings.

What is Oncolytics Biotech, Inc. Common Shares's EBITDA?

Oncolytics Biotech, Inc. Common Shares's EBITDA is -$37.6M, based on as-reported figures from SEC (XBRL) filings.

What is Oncolytics Biotech, Inc. Common Shares's Diluted EPS (TTM)?

Oncolytics Biotech, Inc. Common Shares's Diluted EPS (TTM) is -0.29, based on as-reported figures from SEC (XBRL) filings.

What is Oncolytics Biotech, Inc. Common Shares's Net Debt?

Oncolytics Biotech, Inc. Common Shares's Net Debt is -$4.1M, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Oncolytics Biotech, Inc. Common Shares

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SDGSF3

0.50▲ 0.00 (0.42%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM): —
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 0.50
Day's Range: 0.49 – 0.51
52-Week Range: 0.44 – 1.32
Volume: 375.2K
Avg Volume: 1.2M

Share Statistics

Shares Outstanding
Employees: 29
Exchange: XNAS
Listed: 2001-10-05

Share count as of August 10, 2026

Oncolytics Biotech, Inc. Common Shares (ONCY) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Oncolytics Biotech, Inc. Common Shares (ONCY)

What is Oncolytics Biotech, Inc. Common Shares's Market Cap?: Oncolytics Biotech, Inc. Common Shares's Market Cap is $64.0M, based on as-reported figures from SEC (XBRL) filings.
What is Oncolytics Biotech, Inc. Common Shares's Enterprise Value?: Oncolytics Biotech, Inc. Common Shares's Enterprise Value is $59.9M, based on as-reported figures from SEC (XBRL) filings.
What is Oncolytics Biotech, Inc. Common Shares's EV / EBITDA?: Oncolytics Biotech, Inc. Common Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Oncolytics Biotech, Inc. Common Shares's Net Income (TTM)?: Oncolytics Biotech, Inc. Common Shares's Net Income (TTM) is -$37.5M, based on as-reported figures from SEC (XBRL) filings.
What is Oncolytics Biotech, Inc. Common Shares's EBITDA?: Oncolytics Biotech, Inc. Common Shares's EBITDA is -$37.6M, based on as-reported figures from SEC (XBRL) filings.
What is Oncolytics Biotech, Inc. Common Shares's Diluted EPS (TTM)?: Oncolytics Biotech, Inc. Common Shares's Diluted EPS (TTM) is -0.29, based on as-reported figures from SEC (XBRL) filings.
What is Oncolytics Biotech, Inc. Common Shares's Net Debt?: Oncolytics Biotech, Inc. Common Shares's Net Debt is -$4.1M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · ONCYAs-filed SEC (XBRL) data